Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

BUY
$0.44 - $0.89 $2,094 - $4,237
4,761 New
4,761 $2,000
Q1 2023

May 12, 2023

BUY
$0.56 - $1.32 $7,490 - $17,655
13,375 Added 713.33%
15,250 $9,000
Q4 2022

Feb 08, 2023

BUY
$0.42 - $41.25 $456 - $44,880
1,088 Added 138.25%
1,875 $1,000
Q3 2022

Nov 10, 2022

BUY
$0.26 - $46.35 $204 - $36,477
787 New
787 $2,000

Others Institutions Holding SRZN

About Surrozen, Inc.


  • Ticker SRZN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,122,900
  • Market Cap $371M
  • Description
  • Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, a...
More about SRZN
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.